{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,30]],"date-time":"2026-06-30T19:13:08Z","timestamp":1782846788154,"version":"3.54.5"},"reference-count":30,"publisher":"Oxford University Press (OUP)","issue":"7","license":[{"start":{"date-parts":[[2018,4,1]],"date-time":"2018-04-01T00:00:00Z","timestamp":1522540800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/academic.oup.com\/pages\/standard-publication-reuse-rights"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2018,4,1]]},"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:sec>\n                    <jats:title>Rationale<\/jats:title>\n                    <jats:p>The neuromuscular blocking agent cisatracurium may improve mortality for patients with moderate-to-severe acute respiratory distress syndrome (ARDS). Other neuromuscular blocking agents, such as vecuronium, are commonly used and have different mechanisms of action, side effects, cost, and availability in the setting of drug shortages.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Objectives<\/jats:title>\n                    <jats:p>To determine whether cisatracurium is associated with improved outcomes when compared with vecuronium in patients at risk for and with ARDS.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods<\/jats:title>\n                    <jats:p>Using a nationally representative database, patients who were admitted to the ICU with a diagnosis of ARDS or an ARDS risk factor, received mechanical ventilation, and were treated with a continuous infusion of neuromuscular blocking agent for at least 2 days within 2 days of hospital admission were included. Patients were stratified into two groups: those who received cisatracurium or vecuronium. Propensity matching was used to balance both patient- and hospital-specific factors. Outcomes included hospital mortality, duration of mechanical ventilation, ICU and hospital duration, and discharge location.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Measurements and Main Results<\/jats:title>\n                    <jats:p>Propensity matching successfully balanced all covariates for 3,802 patients (1,901 per group). There was no significant difference in mortality (odds ratio, 0.932; P\u2009=\u20090.40) or hospital days (\u20130.66 d; P\u2009=\u20090.411) between groups. However, patients treated with cisatracurium had fewer ventilator days (\u20131.01 d; P\u2009=\u20090.005) and ICU days (\u20130.98 d; P\u2009=\u20090.028) but were equally likely to be discharged home (odds ratio, 1.19; P\u2009=\u20090.056).<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusions<\/jats:title>\n                    <jats:p>When compared with vecuronium, cisatracurium was not associated with a difference in mortality but was associated with improvements in other clinically important outcomes. These data suggest that cisatracurium may be the preferred neuromuscular blocking agent for patients at risk for and with ARDS.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1164\/rccm.201706-1132oc","type":"journal-article","created":{"date-parts":[[2017,12,14]],"date-time":"2017-12-14T17:12:00Z","timestamp":1513271520000},"page":"897-904","source":"Crossref","is-referenced-by-count":43,"title":["An Observational Study of the Efficacy of Cisatracurium Compared with Vecuronium in Patients with or at Risk for Acute Respiratory Distress Syndrome"],"prefix":"10.1093","volume":"197","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-1071-730X","authenticated-orcid":false,"given":"Peter D.","family":"Sottile","sequence":"first","affiliation":[{"name":"Division of Pulmonary Sciences and Critical Care Medicine and"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tyree H.","family":"Kiser","sequence":"additional","affiliation":[{"name":"Department of Clinical Pharmacy, University of Colorado Skaggs School of Pharmacy, Aurora, Colorado; and"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ellen L.","family":"Burnham","sequence":"additional","affiliation":[{"name":"Division of Pulmonary Sciences and Critical Care Medicine and"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"P. Michael","family":"Ho","sequence":"additional","affiliation":[{"name":"Division of Cardiology, University of Colorado School of Medicine, Aurora, Colorado"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Richard R.","family":"Allen","sequence":"additional","affiliation":[{"name":"Peaks Statistical Consulting, Evergreen, Colorado"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"R. William","family":"Vandivier","sequence":"additional","affiliation":[{"name":"Division of Pulmonary Sciences and Critical Care Medicine and"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marc","family":"Moss","sequence":"additional","affiliation":[{"name":"Division of Pulmonary Sciences and Critical Care Medicine and"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"286","published-online":{"date-parts":[[2018,4,1]]},"reference":[{"key":"2026032023180125500_bib1","first-page":"60","article-title":"Acute respiratory distress in adults. The Lancet, Saturday 12 August 1967 [review of the classics]","volume":"7","author":"Ashbaugh","year":"2005","journal-title":"Crit Care Resusc"},{"key":"2026032023180125500_bib2","first-page":"556","article-title":"Experimental pulmonary edema due to intermittent positive pressure ventilation with high inflation pressures: protection by positive end-expiratory pressure","volume":"110","author":"Webb","year":"1974","journal-title":"Am Rev Respir Dis"},{"key":"2026032023180125500_bib3","doi-asserted-by":"crossref","first-page":"1301","DOI":"10.1056\/NEJM200005043421801","article-title":"Ventilation with lower tidal volumes as compared with traditional tidal volumes for acute lung injury and the acute respiratory distress syndrome","volume":"342","author":"Brower","year":"2000","journal-title":"N Engl J Med"},{"key":"2026032023180125500_bib4","doi-asserted-by":"crossref","first-page":"428","DOI":"10.1056\/NEJMoa1301082","article-title":"A trial of intraoperative low-tidal-volume ventilation in abdominal surgery","volume":"369","author":"Futier","year":"2013","journal-title":"N Engl J Med"},{"key":"2026032023180125500_bib5","doi-asserted-by":"crossref","first-page":"1651","DOI":"10.1001\/jama.2012.13730","article-title":"Association between use of lung-protective ventilation with lower tidal volumes and clinical outcomes among patients without acute respiratory distress syndrome: a meta-analysis","volume":"308","author":"Serpa Neto","year":"2012","journal-title":"JAMA"},{"key":"2026032023180125500_bib6","first-page":"CD011151","article-title":"Intraoperative use of low volume ventilation to decrease postoperative mortality, mechanical ventilation, lengths of stay and lung injury in patients without acute lung injury","volume":"12","author":"Guay","year":"2015","journal-title":"Cochrane Database Syst Rev"},{"key":"2026032023180125500_bib7","doi-asserted-by":"crossref","first-page":"2155","DOI":"10.1097\/CCM.0000000000001189","article-title":"Lung-protective ventilation with low tidal volumes and the occurrence of pulmonary complications in patients without acute respiratory distress syndrome: a systematic review and individual patient data analysis","volume":"43","author":"Neto","year":"2015","journal-title":"Crit Care Med"},{"key":"2026032023180125500_bib8","doi-asserted-by":"crossref","first-page":"438","DOI":"10.1164\/rccm.201605-1081CP","article-title":"Mechanical ventilation to minimize progression of lung injury in acute respiratory failure","volume":"195","author":"Brochard","year":"2017","journal-title":"Am J Respir Crit Care Med"},{"key":"2026032023180125500_bib9","doi-asserted-by":"crossref","first-page":"1107","DOI":"10.1056\/NEJMoa1005372","article-title":"Neuromuscular blockers in early acute respiratory distress syndrome","volume":"363","author":"Papazian","year":"2010","journal-title":"N Engl J Med"},{"key":"2026032023180125500_bib10","doi-asserted-by":"crossref","first-page":"43","DOI":"10.1186\/2110-5820-2-43","article-title":"A fresh look at paralytics in the critically ill: real promise and real concern","volume":"2","author":"Price","year":"2012","journal-title":"Ann Intensive Care"},{"key":"2026032023180125500_bib11","author":"Red Book Online"},{"key":"2026032023180125500_bib12","doi-asserted-by":"crossref","first-page":"2359","DOI":"10.1001\/jama.2010.796","article-title":"Association of corticosteroid dose and route of administration with risk of treatment failure in acute exacerbation of chronic obstructive pulmonary disease","volume":"303","author":"Lindenauer","year":"2010","journal-title":"JAMA"},{"key":"2026032023180125500_bib13","doi-asserted-by":"crossref","first-page":"330","DOI":"10.1177\/0148607111412974","article-title":"Methods to identify and compare parenteral nutrition administered from hospital-compounded and premixed multichamber bags in a retrospective hospital claims database","volume":"36","author":"Mercaldi","year":"2012","journal-title":"JPEN J Parenter Enteral Nutr"},{"key":"2026032023180125500_bib14","doi-asserted-by":"crossref","first-page":"452","DOI":"10.1111\/j.1360-0443.2009.02814.x","article-title":"Moderators and mediators of two brief interventions for alcohol in the emergency department","volume":"105","author":"Barnett","year":"2010","journal-title":"Addiction"},{"key":"2026032023180125500_bib15","doi-asserted-by":"crossref","first-page":"771","DOI":"10.1056\/NEJMoa0707571","article-title":"Aprotinin during coronary-artery bypass grafting and risk of death","volume":"358","author":"Schneeweiss","year":"2008","journal-title":"N Engl J Med"},{"key":"2026032023180125500_bib16","doi-asserted-by":"crossref","first-page":"1553","DOI":"10.1016\/S0140-6736(07)60604-7","article-title":"Acute lung injury and the acute respiratory distress syndrome: a clinical review","volume":"369","author":"Wheeler","year":"2007","journal-title":"Lancet"},{"key":"2026032023180125500_bib17","doi-asserted-by":"crossref","first-page":"788","DOI":"10.1001\/jama.2016.0291","article-title":"Epidemiology, patterns of care, and mortality for patients with acute respiratory distress syndrome in intensive care units in 50 countries","volume":"315","author":"Bellani","year":"2016","journal-title":"JAMA"},{"key":"2026032023180125500_bib18","doi-asserted-by":"crossref","first-page":"94","DOI":"10.1513\/AnnalsATS.201606-438OC","article-title":"Adjuvants to mechanical ventilation for acute respiratory failure: adoption, de-adoption, and factors associated with selection","volume":"14","author":"Munshi","year":"2017","journal-title":"Ann Am Thorac Soc"},{"key":"2026032023180125500_bib19","doi-asserted-by":"crossref","first-page":"1052","DOI":"10.1164\/rccm.201401-0058OC","article-title":"Outcomes associated with corticosteroid dosage in critically ill patients with acute exacerbations of chronic obstructive pulmonary disease","volume":"189","author":"Kiser","year":"2014","journal-title":"Am J Respir Crit Care Med"},{"key":"2026032023180125500_bib20","doi-asserted-by":"crossref","first-page":"8","DOI":"10.1097\/00005650-199801000-00004","article-title":"Comorbidity measures for use with administrative data","volume":"36","author":"Elixhauser","year":"1998","journal-title":"Med Care"},{"key":"2026032023180125500_bib21","article-title":"Pharmacoepidemiology toolbox","author":"Rassen"},{"key":"2026032023180125500_bib22","first-page":"A2779","article-title":"Mortality in intubated patients treated with vecuronium or cisatracurium [abstract]","volume":"195","author":"Sottile","year":"2017","journal-title":"Am J Respir Crit Care Med"},{"key":"2026032023180125500_bib23","doi-asserted-by":"crossref","first-page":"2749","DOI":"10.1097\/01.CCM.0000239435.87433.0D","article-title":"Neuromuscular blocking agents decrease inflammatory response in patients presenting with acute respiratory distress syndrome","volume":"34","author":"Forel","year":"2006","journal-title":"Crit Care Med"},{"key":"2026032023180125500_bib24","doi-asserted-by":"crossref","first-page":"90","DOI":"10.1097\/CCM.0b013e31829eb7c9","article-title":"Treatment with neuromuscular blocking agents and the risk of in-hospital mortality among mechanically ventilated patients with severe sepsis","volume":"42","author":"Steingrub","year":"2014","journal-title":"Crit Care Med"},{"key":"2026032023180125500_bib25","doi-asserted-by":"crossref","first-page":"1176","DOI":"10.1056\/NEJMe1007136","article-title":"Neuromuscular blocking agents in ARDS","volume":"363","author":"Slutsky","year":"2010","journal-title":"N Engl J Med"},{"key":"2026032023180125500_bib26","first-page":"3","article-title":"Comparison of the infusion requirements and recovery profiles of vecuronium and cisatracurium 51W89 in intensive care unit patients","volume":"81","author":"Prielipp","year":"1995","journal-title":"Anesth Analg"},{"key":"2026032023180125500_bib27","doi-asserted-by":"crossref","first-page":"1293","DOI":"10.1056\/NEJMoa1011802","article-title":"Functional disability 5 years after acute respiratory distress syndrome","volume":"364","author":"Herridge","year":"2011","journal-title":"N Engl J Med"},{"key":"2026032023180125500_bib28","doi-asserted-by":"crossref","first-page":"433","DOI":"10.1097\/EDE.0b013e31824d1f63","article-title":"On the nondifferential misclassification of a binary confounder","volume":"23","author":"Ogburn","year":"2012","journal-title":"Epidemiology"},{"key":"2026032023180125500_bib29","doi-asserted-by":"crossref","first-page":"1049","DOI":"10.1186\/1471-2458-14-1049","article-title":"Differential misclassification of confounders in comparative evaluation of hospital care quality: caesarean sections in Italy","volume":"14","author":"Di Martino","year":"2014","journal-title":"BMC Public Health"},{"key":"2026032023180125500_bib30","doi-asserted-by":"crossref","first-page":"175","DOI":"10.1007\/s40471-014-0027-z","article-title":"Misclassification in administrative claims data: quantifying the impact on treatment effect estimates","volume":"1","author":"Funk","year":"2014","journal-title":"Curr Epidemiol Rep"}],"container-title":["American Journal of Respiratory and Critical Care Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/academic.oup.com\/ajrccm\/article-pdf\/197\/7\/897\/67122924\/ajrccm_197_7_897.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"https:\/\/academic.oup.com\/ajrccm\/article-pdf\/197\/7\/897\/67122924\/ajrccm_197_7_897.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,3,21]],"date-time":"2026-03-21T03:18:14Z","timestamp":1774063094000},"score":1,"resource":{"primary":{"URL":"https:\/\/academic.oup.com\/ajrccm\/article\/197\/7\/897\/8498661"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,4,1]]},"references-count":30,"journal-issue":{"issue":"7","published-online":{"date-parts":[[2018,4,1]]},"published-print":{"date-parts":[[2018,4,1]]}},"URL":"https:\/\/doi.org\/10.1164\/rccm.201706-1132oc","relation":{},"ISSN":["1073-449X","1535-4970"],"issn-type":[{"value":"1073-449X","type":"print"},{"value":"1535-4970","type":"electronic"}],"subject":[],"published-other":{"date-parts":[[2018,4]]},"published":{"date-parts":[[2018,4,1]]}}}